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Abstract
Aims We evaluated the effectiveness of a multidisciplinary transition plan to reduce early readmission among heart failure
patients.
Methods and results We conducted a before-and-after study in a tertiary internal medicine department, comparing 3 years
of retrospective data (pre-intervention) and 13 months of prospective data (intervention period). Intervention was the intro-
duction in 2013 of a transition plan performed by a multidisciplinary team. We included all consecutive patients hospitalized
with symptomatic heart failure and discharged to home. The outcomes were the fraction of days spent in hospital because of
readmission, based on the sum of all days spent in hospital, and the rate of readmission. The same measurements were used for
those with potentially avoidable readmissions. Four hundred thirty-one patients were included and compared with 1441 patients
in the pre-intervention period. Of the 431 patients, 138 received the transition plan while 293 were non-completers. Neither the
fraction of days spent for readmissions nor the rate of readmission decreased during the intervention period. However, non-
completers had a higher rate of the fraction of days spent for 30 day readmission (19.2% vs. 16.1%, P = 0.002) and for poten-
tially avoidable readmission (9.8% vs. 13.2%, P = 0.001). The rate of potentially avoidable readmission decreased from 11.3%
(before) to 9.9% (non-completers) and 8.7% (completers), reaching the adjusted expected range given by SQLape® (7.7–9.1%).
Conclusions A transition plan, requiring many resources, could decrease potentially avoidable readmission but shows no
beneﬁt on overall readmission. Future research should focus on potentially avoidable readmissions and other indicators such
as patient satisfaction, adverse drug events, or adherence.
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Introduction
Heart failure (HF) is a well-deﬁned but complex clinical
syndrome characterized by typical signs and symptoms and
caused by structural or functional impairment of ventricular
ﬁlling or ejection of blood. Its prevalence varies between 10
and 20 per 1000 individuals worldwide. Healthcare expendi-
ture attributed to HF approaches 1–2% in Europe and North
America.1 HF is a chronic disease associated with a high risk
of hospitalization and the highest risk of early readmission,
reaching 25%.2–5 In the last decade, reduction of early
readmission, deﬁned as a new hospital admission within
30 days after discharge, has become a major goal for
healthcare systems as a quality and cost indicator.6 Moreover,
the lack of communication between hospital and community
care providers causes ineffective and unsafe discharge.7,8
Transition from hospital to home care is recognized as
critical to reduce readmission. Transitional care is deﬁned
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as a set of actions designed to ensure the coordination and
continuity of healthcare.9 Many interventions on transitional
care have been evaluated, such as follow-up call or
telemonitoring. Recent reviews showed that no single inter-
vention implemented alone was regularly associated with
reduced risk for 30 day readmission. Effective interventions
are complex and should reinforce patient self-care. They tend
to be more comprehensive, extend beyond the hospital stay,
and have the ﬂexibility to respond to individual patient’s
needs.10–12
Reviews focusing on readmission of patients with HF con-
clude that structured telephone support, multidisciplinary
HF clinics, and home-visiting programmes can potentially
reduce readmission, but strength of evidence is low or lacking
for 30 day readmission and of varying degrees for 3–6months’
readmissions.13 Currently, the major limitations and weak-
nesses of the literature on transitional care are the variations
in deﬁnition of the interventions, the need for better evi-
dence, and the high variability of healthcare settings. It makes
a broad implementation of speciﬁc interventions difﬁcult.11,13
It is clear, however, that even the best intervention could
not prevent all readmissions. Halfon et al. deﬁned potentially
avoidable readmissions (PARE) as unforeseen readmissions
for a previously known afﬂiction. They validated the SQLape®
(Striving for Quality Level and Analyzing of Patient Expendi-
tures) algorithm for identiﬁcation of PARE with a sensitivity
and speciﬁcity up to 96%. On the basis of the Swiss national
healthcare register, SQLape® allows estimating the range of
adjusted expected rate of PARE in a deﬁned population.14
As for all-cause readmissions, HF condition is also associated
with a high risk of PARE.15 Readmission is expressed as a rate:
the number of readmissions divided by the number of hospi-
talizations. However, the burden of readmission is better
assessed by the length of stay (LOS). Higher LOS is associated
with higher costs and complications such as hospital-acquired
infections or deconditioning.16
Objectives
Our objective was to assess the effectiveness of a multimodal
care transition plan to reduce the burden of 30 day all-cause
readmissions among adult patients hospitalized with HF in a
general internal medicine department. We chose the fraction
of days spent in hospital because of a readmission (days
spent in readmission over all days spent in hospital during
the study periods) as primary outcome (Figure A1). The
secondary outcomes evaluated the effectiveness of this
transition plan on the PARE.
Methods
Our study followed a before-and-after design with a retro-
spective pre-intervention cohort of HF patients and a
prospective intervention cohort of HF patients. We added a
non-equivalent non-intervention control group composed of
all other hospitalized patients during the same period and
planned a sensitivity analysis.
The study was conducted in the Department of Internal
Medicine at the University Hospital of Lausanne,
Switzerland. Between 2011 and 2013, the department
discharged, on average, 3842 patients annually. They were
mainly admitted from the emergency department (92.3%)
and mostly discharged to home (57.3%).
Enrolment began 1 November 2013 and ended 30
November 2014. Patients could be enrolled at each hospital-
ization. Patients were eligible if they were at least 18 years
old, had HF as an active diagnosis, and were discharged to
home. HF was deﬁned according to the European Cardiology
Society deﬁnition17 or the presence of the appropriate Inter-
national Classiﬁcation of Diseases, Tenth Revision codes in
the medical record (I09.9, I11.0, I13.0, I13.2, I25.5, I42.0,
I42.5 to I42.9, I43.x, I50.x, and P29.0). The study excluded
patients undergoing chronic haemodialysis, asymptomatic
HF stated as New York Heart Association functional class
1, and hospitalizations rejected by the SQLape® algorithm
(i.e. living abroad).
The local human research ethics committee reviewed and
authorized the protocol (reference number: 278/13). In case
of failure to obtain a signed consent form, the patient
received usual care.
Transition plan
A multidisciplinary team of senior physicians, clinical pharma-
cists, and experienced nurses developed the 11 interventions
composing the transition plan. None was part of the usual
care, and the team operated the transition plan
independently from physicians in charge. The details are
given in Table 1 and illustrated in Figure A2.
Data collection
We collected patient characteristics, setting of hospitaliza-
tion, and diagnosis from the medico-administrative database
of the hospital. We ensured identical inclusion and analysis of
before and after groups by using diagnosis coded after
discharge from the discharge summary. We therefore
avoided a selection bias. The transition team had no access
to the statistical analysis results until the end of the study.
Outcomes
The primary outcome measure was the fraction of days spent
in hospital because of a readmission within 30 days after dis-
charge, based on the sum of all days of hospitalization
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Table 1 Transition plan
Components Description Comment and references
Targeted therapeutic education On the basis of existing material of the Swiss
Heart Foundation for the patient,18 the nurse
provided a structured focused education on
self-monitoring, instability signs, and
compliance.
Self-monitoring as weight or breath is
associated with less hospitalization.
Self-care improves outcomes and should
be promoted.19–21
Caregiver therapeutic education The nurse gave the same education to the
caregivers, if the patients had dementia or
language issue.
Caregivers have speciﬁc demands
related to HF patients: physical
limitations, medication, symptoms
monitoring, regime, or disturbed
sleep.22
Medication reconciliation at admission The clinical pharmacist collected three sources
of information to build the best available list of
home medication, certiﬁed during an interview
with the patients.
Pharmacist’s interventions reduce the
morbidity and mortality associated with
heart failure by extending his role from
professional guidance to the delivery of
continuity of care.23
Medication reconciliation at discharge The clinical pharmacist reviewed and proposed
improvement of the discharge prescription, on
the basis of the medication reconciliation on
admission. The patients, the outpatient
pharmacy, and the GP received a commented
medication plan.
Set-up of an appointment with the GP The nurse strongly encouraged the patients to
visit their GP within 7 days after discharge, by
helping them and reminding them during
follow-up calls.
Follow-up appointment prior to
discharge strongly protects against
readmission.24
Notiﬁcation of the GP The nurse sent a message including discharge
date, diagnosis, and medication to the GPs to
improve their awareness.
Communication with the GP is central
for continuity of care and to reduce the
risk of rehospitalization.25
Community nurses notiﬁcation If the patients beneﬁted from community nurses
services, they were informed about the
transition plan either in writing or by phone.
Poor communication between
community nurse and physician is
associated with an increased risk of
hospital readmission among high-risk
patients.26
Patient-centred discharge instructions Before discharge, patient’s awareness was
challenged with three questions: What is my
diagnosis? What is my medication? When and
where is my next appointment?
Interactive communication strategy
improves the comprehension of the
patient.27,28
Follow-up call The nurse called the patients at the 3rd, 7th,
and 18th days after discharge, using a
structured interview to identify instability signs,
motivate the patients to self-monitor, and, if
needed, to call their GPs. The calls were
supervised by the senior physician.
Counselling and monitoring through
frequent telephone follow-up reduce
signiﬁcantly admissions for heart
failure.29
Optional consultation To overcome unavailability of GPs, the patients
might ask for a follow-up visit at hospital, within
the week after discharge.
Early follow-up visit after discharge may
be effective to reduce all-cause
readmission, emergency department
visits, and mortality.30
Hotline During ofﬁce hours, the patients could call the
nurse for any reason.
Patient hotline provides an effective
complementary intervention to
follow-up calls.31
GP, general practitioner; HF, heart failure.
The transition plan was provided by a trained nurse acting as a coordinator. The medication reconciliations were performed by a pharma-
cist. All cases were discussed with a senior physician as clinical supervisor.
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(illustrated in Figure A1). In case of a second readmission, the
ﬁrst readmission was analysed as an index hospitalization and
the patient was included twice. We also measure the 30 day
all-cause readmission rate.
The secondary outcomes were (i) the fraction of days
spent in hospital because of a PARE based on the sum of all
days of hospitalization, (ii) the rate of PARE and the compar-
ison to the adjusted expected interval calculated by SQLape®,
and (iii) the readmission-free survival estimates.
Data analysis
We deﬁned two cohorts of HF patients, one for the pre-
intervention period and one for the intervention period.
Within the intervention period cohort, we also distinguished
the hospitalizations of HF patients who received the transi-
tion plan (‘receivers’) from those who did not complete the
plan (‘non-completers’).
The SQLape® software version 2014 (SQLape SARL,
Switzerland), including gender, age, admission mode, LOS, di-
agnosis, procedures, and other variables—was used to iden-
tify PARE and calculate adjusted expected range of PARE.32
Descriptive measures of variables were calculated and pre-
sented as means and standard deviations. χ2 test and
Wilcoxon tests were used to compare patients’ characteris-
tics between pre-intervention and intervention periods. We
used a multivariate logistic regression to compare
readmissions and PARE. We used STATA 14 (Stata Corp,
College Station, TX, USA) to perform the analysis.
Readmission data from all patients hospitalized in our de-
partment of internal medicine were collected during the
study period to detect general trend of readmission. A sensi-
tivity analysis comparing patients who beneﬁted from the
transition plan (receivers vs. non-completers) was performed.
Results
Figure 1 shows the ﬂow diagram of screening and enrolment
of participants. In the pre-intervention period, 1441 hospital-
izations were eligible. In the intervention period, 431 hospi-
talizations were included for analysis. In 293 out of 431
hospitalizations, patients (non-completers) did not complete
the transition plan: 130 were diagnosed for HF after screen-
ing, 111 were discharged before enrolment, and 52 refused
to give their consent. The remaining 138 patients received
the transition plan.
Table 2 shows characteristics of patients and hospitaliza-
tions during the pre-intervention and intervention periods.
Patients were similar except for age: patients in the interven-
tion period were signiﬁcantly older (+1.8 years, P-value
0.016). However, the multivariate analysis did not identify
age as a signiﬁcant variable.
Completion of the transition plan
Actions taking place right before discharge had a lower rate
of completion. On average, the transition team needed
Figure 1 Flow diagram of screening and enrolment of participants. Medical records were screened according to discharge date and diagnosis codes.
Hospitalizations rejected by the SQLape algorithm were excluded. HF, heart failure; NYHA 1, New York Heart Association functional class 1 (asymptom-
atic HF); PARE, potentially avoidable readmission.
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3.25 h of work to complete one transition plan. The medica-
tion reconciliation was the most time-consuming task. More-
over, overhead time (administration, visiting wards,
screening, meeting, and supervision of team) accounted for
5 to 6 h per opening day. Table A1 shows the different rates
of realization of the components of the transition plan.
Thirty-day readmissions of heart failure patients
and general population
For HF patients, the per cent of days spent in hospital because
of a 30 day readmission during the intervention period
reached 18.1% (1213/6689 days), signiﬁcantly higher than that
Table 2 Characteristics of the 1441 hospitalizations studied during the pre-intervention period and 431 in the intervention period
Pre-intervention period Intervention period
% % P-value
Number of hospitalizations (n) 1441 431
Patient characteristics
Mean age (years old ± SD) 76.4 ± 12.6 78.2 ± 12.4 0.016a
Female 661 45.9 203 47.1 0.653
Married 669 46.4 186 43.2 0.232
General insuranceb 1299 90.1 397 92.1 0.220
Lives in the same sanitary region as hospital 1172 81.3 344 79.8 0.481
Incident hospitalization
Admission
Unplanned admission 1373 95.3 407 94.4 0.474
Need of urgent care (E.S.T score ≤ 2) 907 66.0c 264 65.0c 0.726
Admission on weekend 270 18.7 81 18.8 0.979
Admission by night 435 30.2 147 34.1 0.123
First complaint at admission
Chest pain 154 10.7 48 11.1 0.792
Dyspnoea 748 51.9 210 48.7 0.246
Arrhythmia 94 6.5 19 4.4 0.106
Shock 33 2.3 6 1.4 0.252
Other 346 24.0 123 28.5 0.057
Unavailable 66 4.6 25 5.8 0.301
Hospitalization
Average length of stay (days ± SD) 15.4 ± 12.4 15.5 ± 12.4 0.487
>8 medications at discharge 1044 75.4 324 77.9 0.305
≥4 hospitalizations within the last year 357 24.8 121 28.1 0.168
Principal diagnosis
Congestive heart failure 624 43.3 186 43.2 0.957
Acute myocardial infarct 95 6.6 28 6.5 0.944
Pneumonia 42 2.9 9 2.1 0.355
Respiratory failure 90 6.2 21 4.9 0.290
Atrial ﬁbrillation or ﬂutter 64 4.4 18 4.2 0.814
COPD 40 2.8 11 2.6 0.802
Sepsis 24 1.7 7 1.6 0.953
COPD, chronic obstructive pulmonary disease.
aP-value considered as signiﬁcant.
bNon-general insurances include private and semi-private insurance, more expensive, allowing daily senior attending physician visit and a
single-bed room.
cData were available for 1375 (pre-intervention period) and 406 (intervention period) hospitalizations. Echelle Suisse de Triage (E.S.T)
Swiss triage scale from 1 to 4. Level 2 patients must be treated in <20 min.
Table 3 Outcomes
Pre-intervention period Intervention period P-value
Sum of days spent in hospital by HF patients 22 235 6689
Days due to any readmission within 30 days 3451 (15.5%) 1213 (18.1%) <0.001
Days due to a PARE within 30 days 2553 (11.5%) 805 (12.0%) 0.520
Hospitalizations of HF patients 1441 431
Followed by any readmission within 30 days 276 (19.2%) 91 (21.1%) 0.368
Followed by a PARE within 30 days 163 (11.3%) 41 (9.5%) 0.293
Range of adjusted expected rate of PARE 7.6–9.0% 7.8–9.1% N/A
N/A, not applicable; PARE, potentially avoidable readmission.
The ranges of adjusted expected rate of PARE are calculated with the SQLape® (Striving for Quality Level and Analyzing of Patient Expen-
ditures) algorithm.
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in the pre-intervention period, which was at 15.5% (3451/
22 235 days, P-value< 0.001; Table 3). The rate of hospitaliza-
tions followed by a readmission within 30 days was higher dur-
ing the intervention period (21.1% vs. 19.2%, P-value 0.368).
However, during the same periods, 30 day readmission
also increased in the general population hospitalized in the
department of internal medicine. The per cent of days spent
in hospital by patients without HF because of a 30 day
readmission was 17.6% (13 617/77 461 days) in the pre-
intervention period and signiﬁcantly increased to 18.9%
(4763/25 188, P-value < 0.001) during the intervention
period. The rate of readmission of patients without HF
increased as well (18.4% vs. 19.9%, P-value 0.134) but was
not signiﬁcant (Figure 2).
Figure 2 Rates of hospitalizations followed by a 30 day readmission: comparison of the pre-intervention and intervention periods among hospitaliza-
tions of patients with HF (on the right) and hospitalizations in our internal medicine department of patients without HF (on the left) after being
discharged to home. Hospitalizations of patients with HF show an increased rate of all cause readmissions and a decreasing rate of PARE. This leads
to a signiﬁcant reduction of the ratio PARE/total readmissions (P-value 0.020). During the study period, overall readmission rate increased, while PARE
rate remains stable. Red range stands for adjusted expected range of PARE in each group, according to the SQLape® algorithm. PARE, potentially avoid-
able readmission.
Table 4 Sensitivity analysis: comparison of the ‘non-completers’ vs. ‘receivers’ groups in the intervention period
Non-completers Receivers P-value
Sum of days spent in hospital by HF patients 4435 2254
Days due to any readmission within 30 days 851 (19.2%) 362 (16.1%) 0.002
Days due to a PARE within 30 days 585 (13.2%) 220 (9.8%) <0.001
Hospitalizations of HF patients 293 138
Followed by any readmission within 30 days 60 (20.5%) 31 (22.5%) 0.637
Followed by a PARE within 30 days 29 (9.9%) 12 (8.7%) 0.692
Range of adjusted expected rate of PARE 7.8–9.2% 7.7–9.1% N/A
N/A, not applicable; PARE, potentially avoidable readmission.
The ranges of adjusted expected rate of PARE are calculated with the SQLape® (Striving for Quality Level and Analyzing of Patient Expen-
ditures) algorithm.
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Potentially avoidable readmissions of heart
failure patients
The per cent of days spent in hospital because of a PARE was
similar in the pre-intervention and intervention periods (11.5
vs. 12.0%, P-value 0.520; Table 3). The rate of hospitalizations
followed by a PARE decreased from 11.3% (163 PARE/1441
hospitalizations) in the pre-intervention cohort to 9.5% (41
PARE/431 hospitalizations, P-value 0.293) in the intervention
cohort. Although this difference is not signiﬁcant, this rate
approached the adjusted expected range of 7.8–9.1% PARE,
calculated by SQLape® (Figure 2). Moreover, the ratio of PARE
over total readmissions is signiﬁcantly reduced, meaning—af-
ter adjustment for age, sex, sanitary region, and frequency of
hospitalization—the risk of PARE is reduced to half (adjusted
odds ratio 0.55, P-value 0.020).
Sensitivity analysis
Table 4 details the results of the sensitivity analysis in the in-
tervention cohort, between receivers and non-completers.
The per cent of days spent in hospital because of a 30 day re-
admission was signiﬁcantly lower in the receivers group
(16.1% vs. 19.2%, P-value 0.002). The two groups show no
signiﬁcant difference in rate of readmission (8.7% vs. 9.9%),
but the PARE rate of the receivers group lies in the adjusted
expected range given by SQLape® (7.8–9.1%; Figure 3).
Discussion
Our before-and-after study aimed to evaluate the impact of a
transition plan for HF patients on 30 day readmissions and on
PARE. The results highlighted that the transition plan for HF
patients discharged from hospital to home failed to reduce
30 day readmissions, for either the primary outcome (per
cent of days spent in readmission) or the rate of readmission.
However, the rate of PARE decreased from 11.3% to 9.5% but
did not reach signiﬁcance. Furthermore, we found in the
comparison of receivers versus non-completers group that
the PARE rate signiﬁcantly decreased from 11.1% to 8.7% in
the group who received the transition plan.
As seen in other studies, reaching signiﬁcance on
readmissions rate in transition care studies is challenging.33
We identiﬁed other studies evaluating similar interventions,
although transition care highly depends on local healthcare
systems. A randomized controlled trial of an outpatient
inter-professional management programme for HF patients
in Switzerland had a non-signiﬁcant increased rate of read-
mission in the intervention group.34 In the BEAT-HF study, a
large randomized controlled trial, the combination of
telemonitoring and transition care also failed to reduce
30 day readmission.35 The systematic review of Feltner et al.
found little evidence in favour of interventions reducing early
readmission but conﬁrms the beneﬁt of multidisciplinary HF
clinics on 6 month readmission.13
The outcome measure for transition care is usually the re-
admission rate, because it is an indicator of the disease and
symptoms control, and the efﬁciency of care. However, not
all readmissions are preventable: Unavoidable chronic condi-
tions, such as HF, socio-economic status, elderly, or external
factors, lead to repeated admissions.36,37 For example, an
overcrowded medical unit (and overloaded staff) could press
for anticipation of discharge before complete clinical recov-
ery and favour readmissions. For this reason, it is important
to evaluate the impact of transition care on PARE. Given
the increasing pressure to improve quality and the ﬁnancial
incentives associated with quality measures in general, a ben-
eﬁcial effect on PARE is particularly welcome. Patients at risk
Figure 3 Readmission-free survival estimates between the receivers and non-completers groups. Both (A) and (B) show no signiﬁcant difference at
30 days. PARE, potentially avoidable readmission.
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for PARE may be identiﬁed before discharges using the HOS-
PITAL score.38,39 However, to date, no intervention studies
have been able to demonstrate a 30 day decrease in PARE.
Our transition plan was able to demonstrate a decrease of
PARE that reached the adjusted expected range given by
SQLape®. Furthermore, the time to readmission for PARE
was delayed. This information is important only if the quality
systems focus on readmissions at 15 or 20 days and not at
30 days. Recently, an intervention (during and/or following
hospital discharge) targeting patients at high risk of readmis-
sion has demonstrated a decrease risk of 15 day readmis-
sion.40 However, to obtain such a beneﬁt, money and time
must be invested. We describe later the difﬁculties we have
encountered.
The selection of patients is very demanding. The transition
team identiﬁed each new HF patient at admission and also
screened every single medical record every day to identify
new diagnosis during hospitalization, based on European So-
ciety of Cardiology criteria for HF.17 We included patients
hospitalized with HF and going home. Unfortunately, orienta-
tion at discharge was subject to sudden changes: Even if a
stay in a rehabilitation centre was planned during the entire
stay, the physician in charge might decide on the last day—
with the patient and the family—to let the patient go home;
we had no chance to provide a discharge plan in a short time.
Conversely, if a patient is suddenly not going home because
he or she was transferred to surgery, or even died, we lost
the efforts put in the discharge plan. We spent many re-
sources by providing a complete or partial transition plan
for a surplus of 53 enrolled patients who could not be in-
cluded afterwards because of late decision to not discharge
to home,28 death before discharge,7 ineligibility for PARE as-
sessment,5 and initiation of haemodialysis.2
The second lesson learned is that the transition plan, tai-
lored to ﬁt patients’ needs, presented a high rate of comple-
tion and therefore conﬁrmed its feasibility, although this
complexity was inevitable. Time is the critical resource for
our plan. For example, we performed complete medication
reconciliation, at admission and discharge, but it required
~1.5 h per patients. Overall, patients gave a positive feedback
about the plan, particularly the follow-up phone calls.
Should we drop transition care because of the difﬁculty to
show the effectiveness of a transition plan? We believe that
the beneﬁt cannot just be a marginal reduction of readmis-
sion rate. Decrease of stress related to hospitalization, better
adherence to medication, and reduction of post-discharge
adverse drug event could also be indicators of success.41
Strengths and limitations
Our study resents a major effort to improve transition care at
discharge of HF patients. Because of consecutive inclusion
with few exclusion criteria, the transition team worked in real
conditions. Investigators were blinded until the end of the in-
tervention period, because outcome measures (readmission)
were extracted from medico-administrative database after-
wards. Furthermore, physicians in charge of the patient were
independent of the transition team.
Our study has limitations. Despite daily review of all med-
ical record, one-third (138) only of the targeted population
received the intervention, potentially explaining the non-
signiﬁcant outcome. As discussed earlier, screening and iden-
tifying patients for the transition plan were challenging, like
in other studies.42 Less autonomous patients, confused pa-
tients, and foreign language-speaking patients were more
likely to refuse to give consent, inducing a selection bias. It
would likely have been the same issue while implementing
a permanent transition team. Secondly, the before-and-after
study design is subject to bias: The population characteristic
and the overall readmission rate varied across time. However,
although it increased signiﬁcantly during the study, age was
not identiﬁed as a signiﬁcant variable in a multivariate analy-
sis. It might be that older people receive more support and
therefore compensate the risk for 30 day readmission. More-
over, age is not part of the HOSPITAL score predicting read-
mission.39 Still, we cannot exclude coding and calculation
variation.
Thirdly, readmissions in another hospital, death outside
hospital, and patient moving abroad could not be identiﬁed
in the retrospective pre-intervention cohort, because our
outcome measurements were based on the available
medico-administrative database.
Finally, we performed our study in a single hospital, so
there is a limit to external validity. Some systematic reviews
already recognized this limitation.10 However, an effective
transition plan would have to be adapted to local
healthcare system, while being based on clinical guidelines
related to HF.
Conclusions
A transition plan is feasible and is likely to improve transition
to home for HF patients. It requires, however, many re-
sources, and the beneﬁt represented by the reduction of
readmissions is not clear. Future research should focus more
on PARE than on readmission rate, and on other indicators
like stress related to hospitalizations, patient satisfaction, ad-
verse drug events, or adherence.
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Figure A1 Burden of readmission: more than just a readmission rate, primary outcome takes lengths of stay into account. We considered the ratio of
days spent in readmission over all days spent in hospital during the study periods. Each line corresponds to a patient, and each box is a hospitalization
with various lengths of stay. Grey boxes are hospitalizations considered as 30 day readmission.
Figure A2 Timeline of the transition plan. Each intervention is described in the Table 1. Many are taking place after decision of discharge and are
therefore challenging to provide in time. GP, general practitioner.
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